CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
76 hedge funds and large institutions have $155M invested in Cascadian Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 21 closing their positions.
Holders
76
Holders Change
-2
Holders Change %
-2.56%
% of All Funds
1.9%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
27
Reduced
13
Closed
21
Calls
$123K
Puts
$65K
Net Calls
+$58K
Net Calls Change
-$683K
Top Buyers
| 1 |
1
BlackRock
New York
|
$7.19M |
| 2 |
PC
2
Polar Capital
London,
United Kingdom
|
$3.72M |
| 3 |
SH
3
Sandia Holdings
Greenwich,
Connecticut
|
$3.45M |
| 4 |
4
Boston Partners
Boston,
Massachusetts
|
$1.41M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$1.53M |
